Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer
Tecentriq (atezolizumab) - Roche
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Keytruda (pembrolizumab) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/42667292
 
Alfonso Gómez de Liaño; Alina Pirshtuk; Augusto Mota; Francesco Massari; Gowri Sivaramakrishnan; Jakub Kucharz; Javier Molina Cerrillo; Joaquim Bellmunt; Kannan Sridharan; Marc R Matrana; Martin Angel; Matteo Santoni; Ondrej Fiala; Patrizia Giannatempo; Ravindran Kanesvaran; Shilpa Gupta; Thomas Büttner; Tomas Soule; Yüksel Ürün; Zin W Myint
 
Aug 30, 2026
 
Prev Next